Aravind Ramakrishnan, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Travel
    Ineligible company:
    AstraZeneca
    Topic:
    Lymphoma
    Date added:
    06/29/2024
    Date updated:
    06/29/2024
    Relationship end date:
    10/03/2022
Return to 2024 Seattle Cellular Therapy Summit: Updates and Focus on Accessibility